Neuland Laboratories Limited (NEULANDLAB) stock cleared its 6M resistance trendline and is up 6% intraday at ₹22933.0, backed by strong Q1FY27 results.
Fortis Healthcare Limited (NSE: FORTIS) moves up 5% intraday to ₹967.35, approaching resistance at ₹968. This move is backed by strong Q1 FY27 results.
Sai Life Sciences Limited (SAILIFE) reports Q1 FY27 results with ₹554 crore revenue, up 12% YoY, strong CRO growth and sustained pipeline.
Akums Drugs and Pharmaceuticals Limited (NSE: AKUMS) stock price moves up by 5% intraday to ₹698.3, showing a bounce despite the 6M trendline status being in.
Lupin Limited's Q1 FY27 investor presentation highlights strategic growth, key financial metrics, and significant developments.
Healthcare Global Enterprises Limited (HCG) reports Q1 FY27 results with 13% revenue growth, 20% Adjusted EBITDA, and improved margins.
Fortis Healthcare Limited (FORTIS) announces Q1 FY27 results with consolidated revenues up 17.5% to INR 2,545 Cr.
Hikal Limited (NSE: HIKAL) announced Q1 FY27 results with revenue at Rs. 403 Crs, EBITDA margin up 260 bps YoY.
Emcure Pharmaceuticals Limited (EMCURE) reports Q1 FY27 results with revenue up 22.8% and PAT surging 36.2%.
Jeena Sikho Lifecare Limited (NSE: JSLL) stock gains 5% intraday to ₹609.35, showing a rise in the Healthcare sector despite a breakdown trendline status.